CA2000650A1 - Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose - Google Patents
Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atheroscleroseInfo
- Publication number
- CA2000650A1 CA2000650A1 CA 2000650 CA2000650A CA2000650A1 CA 2000650 A1 CA2000650 A1 CA 2000650A1 CA 2000650 CA2000650 CA 2000650 CA 2000650 A CA2000650 A CA 2000650A CA 2000650 A1 CA2000650 A1 CA 2000650A1
- Authority
- CA
- Canada
- Prior art keywords
- heparin
- treatment
- atherosclerosis
- prevention
- vascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2000650 CA2000650A1 (fr) | 1989-10-13 | 1989-10-13 | Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2000650 CA2000650A1 (fr) | 1989-10-13 | 1989-10-13 | Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2000650A1 true CA2000650A1 (fr) | 1991-04-13 |
Family
ID=4143324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2000650 Abandoned CA2000650A1 (fr) | 1989-10-13 | 1989-10-13 | Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2000650A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922690A (en) * | 1996-04-25 | 1999-07-13 | Van Gorp; Cornelius L. | Dermatan disulfate, an inhibitor of thrombin generation and activation |
US6409987B1 (en) | 1999-04-07 | 2002-06-25 | Intimax Corporation | Targeted agents useful for diagnostic and therapeutic applications |
US6518244B2 (en) | 2000-03-09 | 2003-02-11 | Intimax Corporation | Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof |
-
1989
- 1989-10-13 CA CA 2000650 patent/CA2000650A1/fr not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922690A (en) * | 1996-04-25 | 1999-07-13 | Van Gorp; Cornelius L. | Dermatan disulfate, an inhibitor of thrombin generation and activation |
US6409987B1 (en) | 1999-04-07 | 2002-06-25 | Intimax Corporation | Targeted agents useful for diagnostic and therapeutic applications |
US6518244B2 (en) | 2000-03-09 | 2003-02-11 | Intimax Corporation | Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0343241B1 (fr) | Procede inhibant la thrombose arterielle due aux plaquettes | |
DE69212608T2 (de) | Arzneimittel enthaltend oral absorbierbare Glycosaminoglycane | |
JP3388117B2 (ja) | カイガンショウ抽出物に基づく血小板反応性調節剤の調製方法 | |
RU2262933C2 (ru) | Медицинские композиции, содержащие аспирин | |
KR950009094B1 (ko) | 과유지질혈증 및 아테롬성 동맥경화증의 방지 및 치료용 피리독신 유도체를 함유한 제약학적 조성물 | |
EA004047B1 (ru) | Применение глицинбетаина в качестве антитромботического средства | |
JP2004534087A (ja) | 炎症性腸疾患の治療のためのスロデキシドの使用 | |
US5230996A (en) | Use of ascorbate and tranexamic acid solution for organ and blood vessel treatment prior to transplantation | |
Bird et al. | Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities. | |
Crepaldi et al. | Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan current therapeutic effects and perspectives for clinical use | |
US4302577A (en) | Process for preparing CSA or CSC | |
KR20140097132A (ko) | 허혈성 손상을 치료하기 위한 시스테아민 및/또는 시스타민 | |
JP2010013455A (ja) | 体外血液回路における血餅形成を防止するためのオリゴ糖の使用 | |
Dressman et al. | Absorption of flurbiprofen in the fed and fasted states | |
CA2441948A1 (fr) | Glycine-betaine et utilisation correspondante | |
JPH05504785A (ja) | 新規なへパリン誘導体 | |
WO2004037242A1 (fr) | Compositions injectables indolores contenant un sel d'acides 2-arylpropioniques | |
CA2000650A1 (fr) | Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose | |
JP2000026300A (ja) | 血管内皮細胞保護医薬組成物 | |
EP0532706B1 (fr) | REDUCTION D'OCCLUSIONS DE VAISSEAUX CARDIOVASCULAIRES A L'AIDE D'ASCORBATE ET D'INHIBITEURS DE LIAISON DE LA LIPOPROTEINE (a) | |
IE891356L (en) | Method of preventing or reducing venous thrombosis using a¹thromboxane a2 receptor antagonist in conjunction with¹heparin and combination | |
TW577741B (en) | Novel pharmaceutical combination for treating pain comprising paracetamol and buspirone | |
Smeets et al. | Influence of low dose allopurinol on ischaemia—Reperfusion injury during abdominal aortic surgery | |
CA2195863C (fr) | Remede contre l'endotoxinemie et des defaillances d'organes multiples induites par celle-ci | |
WO2000018418A3 (fr) | Inhibition de la falciformation des erythrocytes par n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |